PHK
FATE icon

Point72 Hong Kong’s Fate Therapeutics FATE Stock Holding History

Point72 Hong Kong’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-28,663
Closed -$642K – 627
2022
Q3 		$642K Buy
28,663
+12,608
+79% +$364K 0.02% 663
2022
Q2 		$398K Buy
16,055
+11,421
+246% +$315K 0.01% 782
2022
Q1 		$180K Buy
+4,634
New +$179K 0.01% 999
2021
Q3 		– Sell
-928
Closed -$81K – 2121
2021
Q2 		$81K Buy
+928
New +$74.8K ﹤0.01% 1365
2020
Q3 		– Sell
-470
Closed -$16K – 1285
2020
Q2 		$16K Buy
+470
New +$14K ﹤0.01% 923
2019
Q4 		– Sell
-169
Closed -$3K – 1241
2019
Q3 		$3K Sell
169
-80
-32% -$1.53K ﹤0.01% 841
2019
Q2 		$5K Buy
+249
New +$4.49K ﹤0.01% 927

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Point72 Hong Kong's FATE Position: Q4 2022 in Review

Point72 Hong Kong sold out of Fate Therapeutics (FATE) in Q4 2022, closing a stake of 28,663 shares — an estimated $642K sold.

Point72 Hong Kong first reported a position in FATE in Q2 2019 and held it in 7 quarters. The position peaked at $642K in Q3 2022. 227 funds tracked by Wall St. Rank hold FATE as of Q4 2022.

  • Point72 Hong Kong reported no remaining Fate Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 28,663 Fate Therapeutics shares in Q4 2022, an estimated $642K.
  • Point72 Hong Kong first reported a position in Fate Therapeutics in Q2 2019 and held it in 7 quarters.
  • Point72 Hong Kong's Fate Therapeutics position peaked at $642K in Q3 2022.
  • 227 funds tracked by Wall St. Rank held Fate Therapeutics as of Q4 2022.

Based on Point72 Hong Kong's 13F filing for Q4 2022, filed 14 Feb 2023.